gabapentin has been researched along with Obesity in 5 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " GBP has a favorable adverse effect profile in therapeutic dosing with the most common reported effects being dizziness, fatigue, drowsiness, weight gain, and peripheral edema." | 1.42 | An acute gabapentin fatality: a case report with postmortem concentrations. ( Cantrell, FL; Gary, RD; McIntyre, IM; Mena, O, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rupniewska-Ladyko, A | 2 |
| Malec-Milewska, M | 1 |
| Kraszewska, E | 1 |
| Pirozynski, M | 1 |
| Kendall, MC | 1 |
| Castro-Alves, LJ | 1 |
| Cantrell, FL | 1 |
| Mena, O | 1 |
| Gary, RD | 1 |
| McIntyre, IM | 1 |
1 trial available for gabapentin and Obesity
| Article | Year |
|---|---|
Gabapentin before laparoscopic sleeve gastrectomy reduces postoperative oxycodone consumption in obese patients: a randomized double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Analgesics; Analgesics, Opioid; Double-Blind Method; Drug Utilization; Fema | 2018 |
4 other studies available for gabapentin and Obesity
| Article | Year |
|---|---|
Opioid consumption after surgery: what is clinically significant?
Topics: Analgesics, Opioid; Double-Blind Method; Gabapentin; Gastrectomy; Humans; Laparoscopy; Obesity; Oxyc | 2018 |
The influence of gabapentin on postoperative outcome in obese patients.
Topics: Analgesics; Cyclohexanecarboxylic Acids; Double-Blind Method; Gabapentin; Gastrectomy; Humans; Lapar | 2018 |
An acute gabapentin fatality: a case report with postmortem concentrations.
Topics: Amines; Analgesics; Cardiovascular Diseases; Chromatography, Liquid; Cyclohexanecarboxylic Acids; Fe | 2015 |
Valproate and other anticonvulsants for psychiatric disorders.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Anti-Anxiety Agents; Anticonvulsants; Bipolar | 2000 |